Alliance Global Partners Initiates Coverage On DarioHealth with Buy Rating, Announces Price Target of $12
TD Cowen Maintains Hold on DarioHealth, Lowers Price Target to $8
DarioHealth (DRIO) Q2 2026 Earnings Call Transcript
DarioHealth Corp (DRIO) (Q2 2026) Earnings Call Highlights: Multi-Condition Platform Drives ...
DarioHealth Corp. Q2 2026 Earnings Call Summary
DarioHealth Q2 Earnings Call Highlights
DarioHealth Corp. (DRIO) Reports Q2 Loss, Lags Revenue Estimates
DarioHealth Corp. (DRIO) Q2 2026 Earnings Call Transcript
DarioHealth Reports Second Quarter 2026 Financial Results
DarioHealth Q2 Adj. EPS $(0.72) Beats $(1.22) Estimate, Sales $5.177M Miss $5.923M Estimate
Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand
DarioHealth to Report Second Quarter 2026 Results on Tuesday, August 11, 2026
Dario Launches Integrated GLP-1 Program, Combining Its Digital Chronic Care Platform with Provider-Backed Clinical Care in a Single End-to-End Experience
DarioHealth (DRIO) Moves 12.9% Higher: Will This Strength Last?
Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
DarioHealth Prices Direct Offering Of 3,454,559 Shares At $6.80 Per Share To Long-Term Institutional And New Fundamental Investors
Fortune 50 Employer Awards Dario Contract to Deliver AI-Powered Cardiometabolic Care Platform
DarioHealth Selected By Fortune 50 Employer To Offer Its Integrated Digital Cardiometabolic Care Platform
Dario Expects Proprietary AI Engine DarioIQ™ to Increase Recurring Revenue from Existing Customers by 10-15%
Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.